PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands.\', \'Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.\', \'Human Immunomics Initiative, Department of Epidemiology, Harvard T.H. Chan School of Public Health and Human Vaccines Project, Boston, MA, USA.\', \'Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.\', \'Department of Epidemiology, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands. m.a.ikram@erasmusmc.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10654-021-00729-5
?:hasPublicationType
?:journal
  • European journal of epidemiology
is ?:pmid of
?:pmid
?:pmid
  • 33634346
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.228
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33634346>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33634346>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all